Previous close | 2.3800 |
Open | 2.3900 |
Bid | 2.4000 x 400 |
Ask | 2.4300 x 200 |
Day's range | 2.3500 - 2.4900 |
52-week range | 1.3000 - 10.0900 |
Volume | |
Avg. volume | 372,161 |
Market cap | 132.924M |
Beta (5Y monthly) | 1.99 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Omega Therapeutics ( NASDAQ:OMGA ) First Quarter 2024 Results Key Financial Results Net loss: US$20.1m (loss narrowed...
Omega Therapeutics (OMGA) delivered earnings and revenue surprises of 5.26% and 155.14%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Omega Therapeutics (OMGA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.